Skip to main content
. 2018 May 18;9(1):74–80. doi: 10.3892/br.2018.1099

Figure 2.

Figure 2.

Disease activity of all patients in the trial. The solid lines indicate patients in which Rachmilewitz CAI declined following consumption (responders); the broken lines indicate patients in which Rachmilewitz CAI remained unchanged or increased (non-responders); the dotted lines indicate dropout cases. CAI, clinical activity index.